Automate Your Wheel Strategy on ARGX
With Tiblio's Option Bot, you can configure your own wheel strategy including ARGX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ARGX
- Rev/Share 59.936
- Book/Share 99.8744
- PB 7.0898
- Debt/Equity 0.0071
- CurrentRatio 5.5953
- ROIC 0.1395
- MktCap 43311412476.0
- FreeCF/Share 5.8394
- PFCF 121.5242
- PE 31.5042
- Debt/Assets 0.006
- DivYield 0
- ROE 0.2595
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | ARGX | RBC Capital Mkts | -- | Outperform | -- | $850 | Aug. 25, 2025 |
| Upgrade | ARGX | Deutsche Bank | Hold | Buy | -- | -- | July 8, 2025 |
| Resumed | ARGX | Morgan Stanley | -- | Overweight | -- | $700 | July 3, 2025 |
| Upgrade | ARGX | Robert W. Baird | Neutral | Outperform | -- | $680 | May 13, 2025 |
| Upgrade | ARGX | Bernstein | Market Perform | Outperform | -- | -- | March 17, 2025 |
| Upgrade | ARGX | Deutsche Bank | Sell | Hold | -- | -- | March 12, 2025 |
| Downgrade | ARGX | Deutsche Bank | Hold | Sell | -- | -- | Jan. 17, 2025 |
| Resumed | ARGX | Raymond James | -- | Strong Buy | -- | $605 | Oct. 10, 2024 |
| Downgrade | ARGX | Deutsche Bank | Buy | Hold | -- | -- | Oct. 4, 2024 |
News
argenx to Present at TD Cowen 45th Annual Healthcare Conference
Published: February 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
February 25, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the TD Cowen 45th Annual Healthcare Conference on Monday, March 3, 2025 at 11:50 a.m. ET.
Read More
argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025
Published: February 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
February 20, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 27, 2025 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2024 financial results and provide a fourth quarter business update.
Read More
About argenx SE (ARGX)
- IPO Date 2017-05-18
- Website https://www.argenx.com
- Industry Biotechnology
- CEO Timothy Van Hauwermeiren EMBA,
- Employees 1599